Shoals Technologies Group and First Solar Continue Partnership

(NasdaqGM:SHLS),(NASDAQ:FSLR), PORTLAND, Tenn., March 26, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals”) (Nasdaq: SHLS), a global leader in electrical balance of systems (“EBOS”) solutions for the energy transition market, announced its continued commitment to investment in domestic manufacturing in Alabama with First Solar, Inc. (Nasdaq: FSLR). This partnership enables the two companies to […]

Montreal Comiccon 2025: The Summer’s Biggest Gathering of Fans and Superheroes

MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) — The 15th edition of Montreal Comiccon, presented by Le Journal de Montreal in collaboration with EBOX, Internet Provider, will take place from July 4 to 6, 2025 at the Palais des congres. The event, one of the largest of its kind in Canada, will reunite tens of thousands

Auron Therapeutics Announces Poster Presentation at 2025 AACR Annual Meeting

NEWTON, Mass., March 26, 2025 (GLOBE NEWSWIRE) — Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the Company will present updated preclinical data from its lead program, AUTX-703, during a poster session at the American Association for Cancer Research (AACR) Annual Meeting

Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights

(NASDAQ:OPTN), Company reports fourth quarter and full year 2024 XHANCE net revenue of $22.4 million and $78.2 million, increases of 13% and 10% compared to prior year periods Company reports 23% prescription growth from third quarter 2024 to fourth quarter 2024 YARDLEY, Pa., March 26, 2025 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused

Aya Gold & Silver Reports High-Grade Silver Results at Depth to the West and Near Pit to the East

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce additional high-grade silver drill results from its drill exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Highlights (all intersections are in core lengths) In

Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd(TM) Alcohol Detox Product Lineup for Retail Sales

(NASDAQ:QNTM),(CNSX:QNTM),(Boerse Frankfurt – Freiverkehr:0K91), New Ultra-Portable unbuzzd(TM) Single-Use Powder Sticks in Convenient 8-Pack Display Boxes Now Available for US Retailers TORONTO, March 26, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company“), today announced its licensee Celly Nutrition Corporation (“Celly Nutrition“), the company behind unbuzzd(TM) –

Aclarion Announces Reverse Stock Split

(NASDAQ:ACON),(NASDAQ:ACONW), BROOMFIELD, Colo., March 26, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that effective before market open on Friday March 28, 2025, it

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

(NASDAQ:ASPI),(OtherOTC:PMCCF),(NASDAQ:IPWR),(NASDAQ:NCSM),(NYSE:CIA),(NASDAQ:VANI),(NASDAQ:BNRG),(OtherOTC:RGBP),(Other OTC:EGYF),(NASDAQ:JAGX), MIAMI, March 26, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy,

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

(NASDAQ:AVTX),(NASDAQ:COLL),(NasdaqGM:TRVI),(NYSE:BHVN), WAYNE, Pa. and ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, today announced the appointment of Michael Heffernan as Chairman of the Board of Directors (“Board”). Mr. Heffernan will succeed Dr. Garry Neil as Chairman of the Board. Dr. Neil

PyroGenesis Schedules 2024 Fiscal Year Financial Results and Business Update Conference Call

(TSX:PYR),(OTC US:PYRGF),(Other OTC:PYRGF),(Frankfurt:8PY1), MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis”) (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, today announces that

Scroll to Top